RTHM
YC W22San Francisco, US · Founded 2022 · 10 employees · 2 known investors
RTHM combines artificial intelligence with clinical expertise to help patients with complex and unexplained illnesses find faster paths to diagnosis and treatment. The platform serves patients and healthcare providers within the digital health and diagnostics industry.
Also known as Inc.
AI & Machine LearningDigital HealthHealthtechArtificial IntelligenceConsumer Health ServicesHealth TechTelemedicineUnited States of AmericaAmerica / CanadaFully Remote
Founders & leadership· Y Combinator alumni (W22)
RTHM was founded in 2022 by Ryan Kellogg, Jennifer Curtin, Michael Snyder, and Eduardo Bohrer.
RK
Ryan KellogginCofounder/CEORyan Kellogg holds a PhD in Microfluidics and Systems Biology from ETH Zurich and has developed technology for molecular analysis in blood microsamples. His work applies bioanalytical methods to health monitoring integrated with wearable sensors and symptom tracking.
JC
Jennifer Curtinin𝕏Co-Founder & CMOJennifer Curtin is a physician with over five years of clinical experience treating post-viral illnesses and ME/CFS, including Long COVID. She is a member of the ME/CFS Clinician Coalition and contributed to expert management guidance published in Mayo Clinic Proceedings. At RTHM, she works on streamlining clinical decision-making and treatment protocols for Long COVID and related conditions to enable broader adoption by healthcare providers.
MS

Michael Snyderin𝕏Scientific CofounderHe directs Stanford's Center for Genomics and Personalized Medicine and chaired the university's Genetics Department from 2009 to 2024. Before returning to Stanford, where he had been a postdoctoral researcher, he spent more than two decades on the Yale faculty, chairing the Molecular, Cellular and Developmental Biology Department and directing the Center for Genomics and Proteomics.
EB

Eduardo BohrerinCOO/CFO and CofounderHe joined RTHM in 2022 as director of product strategy and later served as COO/CFO. He previously spent five years at Cardinal Health in strategy and corporate development and as a senior product manager, and holds an MBA from MIT Sloan, where he took part in the Sandbox Innovation Fund Program.
Investors · 2
The YC application· Winter 2022 batch
Alumni Q&A
- How did you decide to apply to Y Combinator? What was your experience applying, going through the batch, and fundraising at demo day?
- The founders applied after being encouraged by a friend of Ryan's who had recently completed YC with his own startup.
Summarized from the founders' answers on their Y Combinator profile.
Competitors · 1
by search overlapCompanies competing with RTHM for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does RTHM do?
- RTHM combines artificial intelligence with clinical expertise to help patients with complex and unexplained illnesses find faster paths to diagnosis and treatment. The platform serves patients and healthcare providers within the digital health and diagnostics industry.
- Who founded RTHM?
- RTHM was founded by Ryan Kellogg, Jennifer Curtin, Michael Snyder, Eduardo Bohrer in 2022.
- Who are RTHM's investors?
- RTHM's investors include Overwater Ventures Llc, Y Combinator.
- Where is RTHM headquartered?
- RTHM is headquartered in San Francisco, US.


